S
Stefania Rosmini
Researcher at St Bartholomew's Hospital
Publications - 80
Citations - 2829
Stefania Rosmini is an academic researcher from St Bartholomew's Hospital. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Medicine. The author has an hindex of 24, co-authored 69 publications receiving 2034 citations. Previous affiliations of Stefania Rosmini include University College Hospital & Barts Health NHS Trust.
Papers
More filters
Journal ArticleDOI
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Marianna Fontana,Silvia Pica,Patricia Reant,Amna Abdel-Gadir,Thomas A. Treibel,Sanjay M Banypersad,Viviana Maestrini,William Barcella,Stefania Rosmini,Heerajnarain Bulluck,Rabya Sayed,Ketna Patel,Shameem Mamhood,Chiara Bucciarelli-Ducci,Carol J. Whelan,Anna S Herrey,Helen J. Lachmann,Ashutosh D. Wechalekar,Charlotte Manisty,Eric B. Schelbert,Peter Kellman,Julian D. Gillmore,Philip N. Hawkins,James C. Moon +23 more
TL;DR: Transmural LGE is determined reliably by PSIR and represents advanced cardiac amyloidosis and the PSIR technique provides incremental information on outcome even after adjustment for known prognostic factors.
Journal ArticleDOI
Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
Ana Martinez-Naharro,Thomas A. Treibel,Amna Abdel-Gadir,Heerajnarain Bulluck,Giulia Zumbo,Daniel S Knight,Tushar Kotecha,Rohin Francis,David F. Hutt,Tamer Rezk,Stefania Rosmini,Candida Cristina Quarta,Carol J. Whelan,Peter Kellman,Julian D. Gillmore,James C. Moon,Philip N. Hawkins,Marianna Fontana +17 more
TL;DR: Asymmetrical hypertrophy, traditionally associated with hypertrophic cardiomyopathy, was the commonest pattern of ventricular remodeling in ATTR and was an independent prognostic factor for survival in this cohort of patients.
Journal ArticleDOI
Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile
Ahmed Merghani,Viviana Maestrini,Viviana Maestrini,Stefania Rosmini,Andrew T Cox,Harshil Dhutia,Rachel Bastiaenan,Sarojini David,Tee Joo Yeo,Rajay Narain,Aneil Malhotra,Michael Papadakis,Mathew G Wilson,Maite Tome,Khaled Alfakih,James C. Moon,Sanjay Sharma +16 more
TL;DR: Most lifelong masters endurance athletes with a low atherosclerotic risk profile have normal CAC scores, and male athletes are more likely to have a CAC score >300 Agatston units or coronary plaques compared with sedentary males with a similar risk profile.
Journal ArticleDOI
Myocardial Edema and Prognosis in Amyloidosis
Tushar Kotecha,Ana Martinez-Naharro,Thomas A. Treibel,Rohin Francis,Sabrina Nordin,Amna Abdel-Gadir,Daniel S Knight,Giulia Zumbo,Stefania Rosmini,Viviana Maestrini,Heerajnarain Bulluck,Roby Rakhit,Ashutosh D. Wechalekar,Janet A. Gilbertson,Mary N. Sheppard,Peter Kellman,Julian D. Gillmore,James C. Moon,Philip N. Hawkins,Marianna Fontana +19 more
TL;DR: Myocardial T2 is higher in untreated AL amyloidosis compared with treated AL and ATTR amyloidsosis, and is a predictor of prognosis in AL amyoidosis, which suggests mechanisms additional to amyloidal infiltration contributing to mortality in amylidosis.
Journal ArticleDOI
Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification Without Hematocrit Sampling.
Thomas A. Treibel,Marianna Fontana,Viviana Maestrini,Silvia Castelletti,Stefania Rosmini,Joanne Simpson,Arthur Nasis,Anish N Bhuva,Heerajnarain Bulluck,Amna Abdel-Gadir,Steven K White,Charlotte Manisty,Bruce S Spottiswoode,Timothy C. Wong,Stefan K. Piechnik,Peter Kellman,Matthew D. Robson,Erik B. Schelbert,James C. Moon +18 more
TL;DR: Synthetic ECV provides validated noninvasive quantification of the myocardial extracellular space without blood sampling and is associated with cardiovascular outcomes.